Drug
14c Idv184001an
14c Idv184001an: highest development phase Phase 1, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]IDV184001AN NCT05974046 | Phase 1 | Opioid Use Disorder |
Latest
No recent events.
Follow 14c Idv184001an on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.